Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) – Research analysts at SVB Leerink cut their Q4 2023 earnings per share (EPS) estimates for shares of Arrowhead Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 2nd. SVB Leerink analyst M. Foroohar now forecasts that the biotechnology company will post earnings of […]
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) posted its quarterly earnings data on Tuesday. The biotechnology company reported $0.45 earnings per share for the quarter, topping the consensus estimate of ($0.65) by $1.10, Briefing.com reports. Arrowhead Pharmaceuticals had a negative net margin of 54.31% and a negative return on equity of 34.73%. The company had revenue […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating)‘s stock had its “reiterates” rating reiterated by 500.com in a research note issued to investors on Wednesday, Benzinga reports. Several other equities research analysts also recently weighed in on the company. B. Riley cut their price target on Arrowhead Pharmaceuticals from $59.00 to $55.00 and set a “buy” rating […]